TXN and neoplasm: This is attributed to augmented Trx and TrxR levels reported to positively correlate with tumor progression, chemo resistance, and poor survival [170,171,172] Presently, several compounds specially targeting Trx are being explored on the scientific front in pre-clinical and clinical models.